Integrity Applications News Today

Premier database and directory of PR firms & public relations agencies. Find the firm that best suits your needs.

GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 70 public companies in the “Medical Instruments & Supplies” industry, but how does it compare to its competitors? We will compare GlucoTrack to related businesses based on the strength of its valuation, dividends, earnings, risk, analyst recommendations, institutional ownership and profitability. Risk and Volatility GlucoTrack has […]

GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 224 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare GlucoTrack to similar companies based on the strength of its profitability, dividends, risk, valuation, earnings, institutional ownership and analyst recommendations. Volatility & Risk GlucoTrack has […]

Former U.S. Space Force leader Frank Di Pentino has been selected as chief strategy officer of True Anomaly. As the first individual to serve in this newly created position, Di Pentino will guide space offerings development, customer support and product scaling to keep the company competitive in space markets, True Anomaly announced from Centennial, Colorado on Thursday.

GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 222 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare GlucoTrack to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation. Volatility and Risk […]

GlucoTrack (NASDAQ:GCTK – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Earnings and Valuation This table compares GlucoTrack […]

Atrion (NASDAQ:ATRI – Get Free Report) and GlucoTrack (NASDAQ:GCTK – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings. Volatility and Risk Atrion has a beta of 0.53, […]

Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board of Directors and as Chair of its Audit Committee, effective immediately. Ms. Carter brings 30 years of executive level finance experience in the medical device industry. From 2012 unti...

25.07.2023 - Rutherford, NJ, July 25, 2023 (GLOBE NEWSWIRE) - - Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today the completion and ...

Dublin, July 05, 2023 (GLOBE NEWSWIRE) -- The "Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva...